background image

Paid Clinical Trials Chattanooga

Discover 128 paid clinical trials in Chattanooga, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Chattanooga TN, Nashville TN, Charlotte NC, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting
Active & Responsive

Esprit BTK Post-Approval Study

for
Chronic Limb-Threatening Ischemia
Location: Chattanooga TN, Atlanta GA, Johnson City TN, Tupelo MS,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06656364

Recruiting
Active & Responsive

Innovative Automated Insulin Delivery System for Type 2 Diabetes

for
Type 2 Diabetes, Insulin Treated Type 2 Diabetes Mellitus
Location: Chattanooga TN, Roswell GA, Atlanta GA, Indianapolis IN,
Sponsor: Deka Research and Development

Sex: All

Age: 18+

Code: NCT06853990

Recruiting
Active & Responsive

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

for
Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative
Location: Chattanooga TN, Charleston SC, Chapel Hill NC,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04468061

Phase2, Recruiting
Active & Responsive

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for
Neoplasms, Head and Neck
Location: Chattanooga TN, Atlanta GA, Nashville TN, Greenville SC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma
Location: Chattanooga TN, Nashville TN, Lexington KY, Swansea IL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06806033

Phase2, Recruiting
Active & Responsive

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Chattanooga TN, Nashville TN, Athens GA, Spartanburg SC,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06497556

Phase3, Recruiting
Active & Responsive

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

for
Platinum-resistant Ovarian Cancer,
Location: Chattanooga TN, Atlanta GA, Charlotte NC, Kettering OH,
Sponsor: Genelux Corporation

Sex: Female

Age: 18+

Code: NCT05281471

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Chattanooga TN, Marietta GA, Gainesville GA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

for
Refractory Rheumatoid Arthritis (RA),
Location: Hixson TN, Tuscaloosa AL, Charlotte NC, Willowbrook IL,
Sponsor: Artiva Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06991114

Phase2, Recruiting